| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Moderna, Inc. (MRNA) has 8 insiders with recent SEC Form 4 filings, including 3 buys and 8 sells. MRNA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Pres | 1.46M | $70.74M | - | |
| Other | 55.9K | $2.71M | - | |
| Dir | 27.8K | $1.35M | - | |
| CFO | 4.4K | $211.6K | - | |
| Dir | 1.5K | $74.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | Afeyan Noubar74 | Director | Sale+OE | 23,853 | $29.49 | $703,305.71 | -85.9% | +88.9% | - | |
| Dec 9, 2025 | Hussain Abbas | Director | Sell | 504 | $27.60 | $13,910.40 | -25.0% | +97.4% | - | |
| Jun 11, 2025 | Hussain Abbas | Director | Sell | 312 | $28.00 | $8,736.00 | -35.0% | -11.8% | - | |
| Mar 3, 2025 | Bancel Stephane72 | Chief Executive Officer | Buy | 160,314 | $31.22 | $5,004,318.13 | +0.9% | -10.6% | +64.6% | |
| Mar 3, 2025 | Sagan Paul | Director | Buy | 31,620 | $31.76 | $1,004,251.20 | +11.3% | -10.6% | +64.6% | |
| Dec 9, 2024 | Klinger Shannon Thyme81 | Chief Legal Officer | Sale+OE | 529 | $44.68 | $23,637.31 | -2.5% | -21.2% | -38.1% | |
| Dec 3, 2024 | Klinger Shannon Thyme81 | Chief Legal Officer | Sale+OE | 112 | $43.30 | $4,849.28 | -0.6% | -28.9% | -40.9% | |
| Dec 3, 2024 | Hoge Stephen74 | President | Sale+OE | 314 | $43.30 | $13,595.29 | - | -28.9% | -40.9% | |
| Nov 29, 2024 | Mock James M85 | Chief Financial Officer | Sale+OE | 1,420 | $42.79 | $60,760.52 | -11.4% | -27.8% | -39.7% | |
| Nov 29, 2024 | Hoge Stephen74 | President | Sale+OE | 291 | $42.79 | $12,451.63 | - | -27.8% | -39.7% |